| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 180,029,134.04 | 4,390,817.96 | 129,590,373.95 | 113,029,527.82 |
| 收到的税费返还 | 2,855,287.63 | - | - | - |
| 收到其他与经营活动有关的现金 | 4,086,129.73 | 1,423,103.15 | 27,922,351.69 | 25,973,383.27 |
| 经营活动现金流入小计 | 186,970,551.4 | 5,813,921.11 | 157,512,725.64 | 139,002,911.09 |
| 购买商品、接受劳务支付的现金 | 24,937,895.82 | 12,413,754.85 | 137,684,478.24 | 98,855,642.02 |
| 支付给职工以及为职工支付的现金 | 15,500,733.36 | 9,894,922.72 | 42,099,583.8 | 30,222,152.58 |
| 支付的各项税费 | 8,198,237.55 | 914,185.84 | 85,793,446.49 | 82,853,402.92 |
| 支付其他与经营活动有关的现金 | 81,651,620.61 | 5,181,522.3 | 33,670,114.53 | 29,696,078.28 |
| 经营活动现金流出小计 | 130,288,487.34 | 28,404,385.71 | 299,247,623.06 | 241,627,275.8 |
| 经营活动产生的现金流量净额 | 56,682,064.06 | -22,590,464.6 | -141,734,897.42 | -102,624,364.71 |
| 二、投资活动产生的现金流量: | | | | |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | 4,093.15 | - | 2,200 | - |
| 投资活动现金流入的平衡项目 | 0 | - | 0 | - |
| 投资活动现金流入小计 | 4,093.15 | - | 2,200 | - |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 65,398.55 | 14,075 | 882,009.76 | 669,451.59 |
| 投资活动现金流出小计 | 65,398.55 | 14,075 | 882,009.76 | 669,451.59 |
| 投资活动产生的现金流量净额 | -61,305.4 | -14,075 | -879,809.76 | -669,451.59 |
| 三、筹资活动产生的现金流量: | | | | |
| 分配股利、利润或偿付利息支付的现金 | - | - | 52,281,975.56 | 52,281,975.56 |
| 支付其他与筹资活动有关的现金 | 2,407,608 | 1,285,884 | 5,449,199.78 | 4,127,939.78 |
| 筹资活动现金流出小计 | 2,407,608 | 1,285,884 | 57,731,175.34 | 56,409,915.34 |
| 筹资活动产生的现金流量净额 | -2,407,608 | -1,285,884 | -57,731,175.34 | -56,409,915.34 |
| 四、汇率变动对现金及现金等价物的影响 | - | - | 73.21 | 73.21 |
| 五、现金及现金等价物净增加额 | 54,213,150.66 | -23,890,423.6 | -200,345,809.31 | -159,703,658.43 |
| 加:期初现金及现金等价物余额 | 365,604,425.87 | 365,604,425.87 | 565,950,235.18 | 565,950,235.18 |
| 期末现金及现金等价物余额 | 419,817,576.53 | 341,714,002.27 | 365,604,425.87 | 406,246,576.75 |
| 补充资料: | | | | |
| 净利润 | -19,143,110.54 | - | 16,978,382.59 | - |
| 资产减值准备 | - | - | 5,193,520.81 | - |
| 固定资产和投资性房地产折旧 | 4,440,605.66 | - | 8,292,401.86 | - |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 1,016,927.12 | - | 2,068,569.43 | - |
| 投资性房地产折旧 | 3,423,678.54 | - | 6,223,832.43 | - |
| 长期待摊费用摊销 | 724,278.64 | - | 1,363,150.59 | - |
| 固定资产报废损失 | 33,897.89 | - | 10,275.66 | - |
| 财务费用 | 198,634.76 | - | 398,528.76 | - |
| 递延所得税 | -4,668,380.24 | - | 7,523,329.51 | - |
| 其中:递延所得税资产减少 | -496,080.52 | - | 9,332,757.64 | - |
| 递延所得税负债增加 | -4,172,299.72 | - | -1,809,428.13 | - |
| 存货的减少 | -13,225,408.07 | - | 98,876,722.72 | - |
| 经营性应收项目的减少 | -819,521.57 | - | -4,225,536.57 | - |
| 经营性应付项目的增加 | 86,917,989.1 | - | -280,513,351.05 | - |
| 现金的期末余额 | 419,817,576.53 | - | 365,604,425.87 | - |
| 减:现金的期初余额 | 365,604,425.87 | - | 565,950,235.18 | - |
| 现金及现金等价物的净增加额 | 54,213,150.66 | - | -200,345,809.31 | - |
| 公告日期 | 2025-08-30 | 2025-04-26 | 2025-03-29 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |